Prevalence of hyperandrogenemia in the polycystic ovary syndrome.

被引:0
|
作者
Huang, A.
Brennan, K. M.
Azziz, R.
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
关键词
D O I
10.1016/j.fertnstert.2006.07.1258
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:S456 / S457
页数:2
相关论文
共 50 条
  • [1] Hypofibrinolysis and hyperandrogenemia: Risk factors for pregnancy failure in polycystic ovary syndrome.
    Glueck, CJ
    Tracy, T
    Sieve-Smith, L
    Wang, P
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (02) : 189A - 189A
  • [2] Prevalence and Impact of Hyperandrogenemia in 1218 Women with Polycystic Ovary Syndrome
    Livadas, Sarantis
    Pappas, Christos
    Karachalios, Athanasios
    Marinakis, Evangelos
    Tolia, Nikoleta
    Drakou, Maria
    Kaldrymides, Phillipos
    Panidis, Dimitrios
    Diamanti-Kandarakis, Evanthia
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [3] Hypofibrinolysis and hyperandrogenemia: Risk factors for pregnancy failure in polycystic ovary syndrome.
    Glueck, CJ
    Tracy, T
    Sieve-Smith, L
    Wang, P
    [J]. FASEB JOURNAL, 2000, 14 (04): : A778 - A778
  • [4] Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome
    Fruzzetti, Franca
    Perini, Daria
    Lazzarini, Veronica
    Parrini, Donatella
    Genazzani, Andrea R.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (05) : 335 - 343
  • [5] Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals
    Mueller, Andreas
    Gooren, Louis J.
    Naton-Schoetz, Susanne
    Cupisti, Susanne
    Beckmann, Matthias W.
    Dittrich, Ralf
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04): : 1408 - 1411
  • [6] Gonadotrophin ovarian stimulation worsens insulin resistance and hyperandrogenemia in women with polycystic ovary syndrome.
    Simonis, CD
    Richardson, MC
    Cameron, IT
    Byrne, CD
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 136A - 136A
  • [7] Hyperandrogenemia is neceesary but not sufficient for polycystic ovary syndrome
    Dunaif, A
    [J]. FERTILITY AND STERILITY, 2003, 80 (02) : 262 - 263
  • [8] Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome
    Sarantis Livadas
    Christos Pappas
    Athanasios Karachalios
    Evangelos Marinakis
    Nikoleta Tolia
    Maria Drakou
    Philippos Kaldrymides
    Dimitrios Panidis
    Evanthia Diamanti-Kandarakis
    [J]. Endocrine, 2014, 47 : 631 - 638
  • [9] Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome
    Chappell, Neil R.
    Gibbons, William E.
    Blesson, Chellakkan S.
    [J]. STEROIDS, 2022, 180
  • [10] BIOLOGIC EFFECTS OF HYPERANDROGENEMIA IN POLYCYSTIC OVARY SYNDROME
    ROSENFIELD, RL
    MAUDELONDE, T
    MOLL, GW
    [J]. SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1984, 2 (03): : 281 - 296